Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...
Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results